US Broker Ratings

IDEXX Laboratories, Inc. (IDXX)

⚠️ No article content returned.

..

Alnylam Pharmaceuticals (ALNY) Stock Analysis: A Strong Buy Opportunity with 47% Upside Potential

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) sits at the forefront of the biotechnology sector, specializing in the groundbreaking field of ribonucleic acid interference (RNAi) therapeutics. With a market capitalization of $39.89..

Stryker Corporation (SYK) Stock Analysis: Unpacking a 17% Potential Upside Amid Robust Market Position

Stryker Corporation (NYSE: SYK) stands as a healthcare titan within the medical devices industry, boasting a formidable market capitalization of $126.42 billion. As a key player in both MedSurg &..

GSK plc (GSK) Stock Analysis: Evaluating the 7.51% Upside Potential in the Healthcare Giant

As one of the stalwarts in the healthcare sector, GSK plc (NYSE: GSK) presents a compelling opportunity for investors looking to capitalize on its strong market position and promising upside..

Sanofi (SNY) Stock Analysis: Discover a Potential 26.56% Upside in the Healthcare Giant

Sanofi (SNY), the Paris-based healthcare titan, stands as a formidable player in the drug manufacturing industry with a market capitalization of $104.13 billion. As an investor focusing on the healthcare..

Danaher Corporation (DHR): Analyst Consensus and Growth Potential with 21.71% Upside

Danaher Corporation (NYSE: DHR), a stalwart in the healthcare sector, is capturing investor attention with its robust potential upside of 21.71%. As a leading player in the diagnostics and research..

Soleno Therapeutics, Inc. (SLNO) Stock Analysis: Steady Performance with Limited Upside in the Biotech Sector

Soleno Therapeutics, Inc. (NASDAQ: SLNO), a prominent player in the biotechnology sector, continues to capture investor attention with its focus on developing treatments for rare diseases. Headquartered in Redwood City,..

Teleflex Incorporated (TFX) Stock Analysis: Exploring an 8.88% Potential Upside Amid Strong Revenue Growth

Teleflex Incorporated (NYSE: TFX) stands as a formidable player in the healthcare sector, specializing in the medical instruments and supplies industry. With a substantial market cap of $5.93 billion, the..

Bruker Corporation (BRKR) Stock Analysis: Navigating a Complicated Landscape Amidst Healthcare Sector Growth

Bruker Corporation (NASDAQ: BRKR) stands at the forefront of the medical devices industry, operating predominantly within the healthcare sector. Headquartered in Billerica, Massachusetts, the company boasts a market capitalization of..

Inspire Medical Systems (INSP) Stock Analysis: Navigating the Medical Device Market with a 10% Upside

Inspire Medical Systems, Inc. (NASDAQ: INSP) has been a compelling player in the healthcare sector, specifically within the medical devices industry. With a focus on innovative treatments for obstructive sleep..

Elanco Animal Health (ELAN) Stock Analysis: A 19.43% Potential Upside for Investors

Elanco Animal Health Incorporated (NYSE: ELAN) has emerged as a noteworthy player within the healthcare sector, specifically in the drug manufacturing niche for specialty and generic products. Headquartered in Indianapolis,..

iRhythm Holdings, Inc. (IRTC) Stock Analysis: A 41% Potential Upside Beckons Investors

iRhythm Holdings, Inc. (NASDAQ: IRTC), a prominent player in the healthcare sector specializing in medical devices, presents an intriguing opportunity for investors as it navigates the dynamic landscape of digital..

Telix Pharmaceuticals Limited (TLX): Investor Outlook Unveils 75% Upside Potential

Telix Pharmaceuticals Limited (TLX), a burgeoning force in the biotechnology sector, is capturing investor attention with its promising growth trajectory and substantial upside potential. With a market capitalization of $4.02..

Ionis Pharmaceuticals, Inc. (IONS) Stock Analysis: Exploring a 29.48% Potential Upside in the Biotech Sphere

Ionis Pharmaceuticals, Inc. (NASDAQ: IONS), a prominent player in the biotechnology sector, is attracting investor attention with its potential upside of 29.48%. With a current stock price of $81.80, Ionis..

ADMA Biologics Inc (ADMA) Stock Analysis: High Potential Upside Amid Robust Growth Trends

ADMA Biologics Inc (NASDAQ: ADMA), a pioneering player in the biotechnology sector, is poised for substantial growth, offering a remarkable potential upside of 96.65%. This healthcare company, with a market..

TG Therapeutics, Inc. (TGTX) Investor Outlook: Navigating Growth with High Potential in Biotech

TG Therapeutics, Inc. (NASDAQ: TGTX), a key player in the biotechnology sector, stands out with its strategic focus on developing innovative treatments for B-cell mediated diseases. Headquartered in Morrisville, North..

Grifols, S.A. (GRFS) Stock Analysis: A 51.75% Upside Potential in the Healthcare Sector

Grifols, S.A. (NASDAQ: GRFS), a key player in the healthcare sector, is drawing attention from investors with its substantial potential upside of 51.75%, as indicated by the average target price..

Incyte Corporation (INCY) Stock Analysis: Navigating Growth with a Robust Pipeline and Strong Revenue Growth

For investors eyeing the healthcare sector, Incyte Corporation (NASDAQ: INCY) presents a compelling opportunity, primarily driven by its robust revenue growth and impressive return on equity. As a key player..

Guardant Health, Inc. (GH) Stock Analysis: A Promising Path in Precision Oncology Despite Financial Hurdles

Guardant Health, Inc. (NASDAQ: GH) is carving out a significant niche in the healthcare sector, specifically within diagnostics and research. Headquartered in Palo Alto, California, this precision oncology company has..

Oscar Health, Inc. (OSCR) Stock Analysis: Navigating Market Uncertainties with a Strong Revenue Growth

Oscar Health, Inc. (NYSE: OSCR), a forward-thinking healthcare technology company, is catching the attention of investors with its dynamic approach to health plans and technology solutions. Headquartered in New York,..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds